|Articles|September 7, 2021

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Brad Hertz is a BRCA2 previvor who enrolled himself in a clinical trial for prostate cancer.

Clinical trials and research studies are how we move science and research forward. During Prostate Cancer Awareness Month we honor all those with, or at risk for, prostate cancer and we share this story of Brad Hertz, BRCA2 previvor who enrolled himself in a prostate cancer clinical trial at the National Institutes of Health.

https://facingourrisk.org/blog/a-different-kind-of-trial-a-litigation-attorneys-take-on-being-in-a-national-institutes-of-health-clinical-trial/?utm_source=CURE&utm_medium=website

Stay up to date on cancer updates, research and education

Subscribe Now!

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Newsletter

Trending on CURE

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

Suleika Jaouad, Reporting From the Front Lines of Leukemia

FDA Grants Priority Review for Opdivo Combo in Advanced Lymphoma

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey